Publicação:
Inhibition of Lysozyme by Taurine Dibromamine

dc.contributor.authorPetronio, M. S. [UNESP]
dc.contributor.authorXimenes, Valdecir Farias [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-12-03T13:11:46Z
dc.date.available2014-12-03T13:11:46Z
dc.date.issued2013-11-01
dc.description.abstractHypobromous acid (HOBr) is a powerful oxidant produced by stimulated neutrophils and eosinophils. Taurine, a non-protein amino acid present in high amounts in the leukocytes, reacts instantaneously with HOBr leading to their haloamine derivative taurine dibromamine (Tau-NBr2). Lysozyme is a bactericidal enzyme also present in leukocytes and in secretory fluids. The inhibition of lysozyme is a pathway for bacterial proliferation in inflammatory sites. Here, we investigated the inhibition of the enzymatic activity of lysozyme when it was submitted to oxidation by Tau-NBr2. We found that the oxidation of lysozyme by Tau-NBr2 decreased its enzymatic activity in 80%, which was significant higher compared to the effect of its precursor HOBr (30%). The study and comparison of Tau-NBr2 and HOBr regarding the alterations provoked in the intrinsic fluorescence, synchronous fluorescence, resonance light scattering and near and far-UV circular dichroism spectra of lysozyme and oxidized lysozyme revealed that tryptophan residues in the active site of the protein were the main target for Tau-NBr2 and could explain its efficacy as inhibitor of lysozyme enzymatic activity. This property of Tau-NBr2 may have pathological significance, since it can be easily produced in the inflammatory sites.en
dc.description.affiliationSao Paulo State Univ UNESP, Fac Sci, Dept Chem, BR-17033360 Sao Paulo, Brazil
dc.description.affiliationSao Paulo State Univ UNESP, Sch Pharmaceut Sci, Dept Clin Anal, BR-14801902 Sao Paulo, Brazil
dc.description.affiliationUnespSao Paulo State Univ UNESP, Fac Sci, Dept Chem, BR-17033360 Sao Paulo, Brazil
dc.description.affiliationUnespSao Paulo State Univ UNESP, Sch Pharmaceut Sci, Dept Clin Anal, BR-14801902 Sao Paulo, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.format.extent1232-1237
dc.identifierhttp://dx.doi.org/10.2174/0929866511320110007
dc.identifier.citationProtein and Peptide Letters. Sharjah: Bentham Science Publ Ltd, v. 20, n. 11, p. 1232-1237, 2013.
dc.identifier.issn0929-8665
dc.identifier.lattes4066413997908572
dc.identifier.urihttp://hdl.handle.net/11449/113537
dc.identifier.wosWOS:000324541700007
dc.language.isoeng
dc.publisherBentham Science Publ Ltd
dc.relation.ispartofProtein and Peptide Letters
dc.relation.ispartofjcr1.039
dc.relation.ispartofsjr0,429
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectEosinophilsen
dc.subjecthypobromous aciden
dc.subjecthypochlorous aciden
dc.subjectlysozymeen
dc.subjectneutrophilsen
dc.subjecttaurine dibromamineen
dc.titleInhibition of Lysozyme by Taurine Dibromamineen
dc.typeArtigo
dcterms.rightsHolderBentham Science Publ Ltd
dspace.entity.typePublication
unesp.author.lattes4066413997908572
unesp.author.orcid0000-0003-2636-3080[2]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências, Baurupt
unesp.departmentQuímica - FCpt
unesp.departmentAnálises Clínicas - FCFpt

Arquivos